Sushil Kumar

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Endoplasmic Reticulum

Top Venues

Nature communications

Cancer research

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Amlan Barai, Niyati Piplani, Sumon Kumar Saha, Sarbajeet Dutta, Gomathi V, Mayank M Ghogale, Sushil Kumar, Madhura Kulkarni, Shamik Sen
Bulky glycocalyx drives cancer invasiveness by modulating substrate-specific adhesion. PNAS nexus 3 (8) (2024)
Sarah B Gitto, Margaret E Whicker, Gareth Davies, Sushil Kumar, Krista Kinneer, Haineng Xu, Arthur Lewis, Srinivas Mamidi, Sergey Medvedv, Hyoung Kim, Judith Anderton, E Jessica Tang, Benjamin Ferman, Steven Coats, Robert W Wilkinson, Eric J Brown, Daniel J Powell, Fiona Simpkins
A B7-H4 targeting antibody-drug conjugate shows anti-tumor activity in PARPi and platinum resistant cancers with B7-H4 expression. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sushil Kumar, Ajeya Nandi, Snahlata Singh, Rohan Regulapati, Ning Li, John W Tobias, Christian W Siebel, Mario Andres Blanco, Andres J Klein-Szanto, Christopher J Lengner, Alana L Welm, Yibin Kang, Rumela Chakrabarti
Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway. Nature communications 13 (1) (2022)
Christoforos Thomas, Ilias V Karagounis, Ratnesh K Srivastava, Nicholas Vrettos, Fotis Nikolos, Noëlle Francois, Menggui Huang, Siliang Gong, Qi Long, Sushil Kumar, Constantinos Koumenis, Savitri Krishnamurthy, Naoto Tada Ueno, Rumela Chakrabarti, Amit Maity
Estrogen Receptor β-Mediated Inhibition of Actin-Based Cell Migration Suppresses Metastasis of Inflammatory Breast Cancer. Cancer research 81 (9) (2021)
Sushil Kumar, Ajeya Nandi, Snahlata Singh, Rohan Regulapati, Ning Li, John W Tobias, Christian W Siebel, Mario Andres Blanco, Andres J Klein-Szanto, Christopher J Lengner, Alana L Welm, Yibin Kang, Rumela Chakrabarti
Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway. Nature communications 12 (1) (2021)